Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STT3A | P46977 | 1/20 | 0.70 |
| ▸ | STT3B | Q8TCJ2 | 1/20 | 0.70 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25227417 | 0.92 | STT3A (0.71) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726115 | 0.91 | STT3A (0.70) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726323 | 0.90 | STT3A (0.73) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726374 | 0.89 | STT3A (0.64) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726033 | 0.89 | STT3A (0.63) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726372 | 0.89 | STT3A (0.71) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726114 | 0.89 | STT3A (0.63) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726407 | 0.89 | STT3A (0.63) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726039 | 0.88 | STT3A (0.62) | STT3ASTT3BGFERTSHRMAPK1 | |
| SCHEMBL25726409 | 0.87 | STT3A (0.70) | STT3ASTT3BGFERTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023114428-A1 | HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF DISEASE | Vir Biotechnology, Inc. (US) | 2023-06-22 | — | — | WO | disclosed |